Literature DB >> 19017927

Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.

Hyun Kyung Lim1, Jeong Kon Kim, Kyung Ah Kim, Kyoung-Sik Cho.   

Abstract

PURPOSE: To retrospectively assess the incremental value of an apparent diffusion coefficient (ADC) map combined with T2-weighted magnetic resonance (MR) images compared with T2-weighted images alone for prostate cancer detection by using a pathologic map as the reference standard.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board; informed consent was waived. The study included 52 patients (mean age, 65 years +/- 5 [standard deviation]; range, 48-76 years) who underwent endorectal MR imaging and step-section histologic examination. Three readers with varying experience levels reviewed T2-weighted images alone, the ADC map alone, and T2-weighted images and ADC maps. The prostate was divided into 12 segments. The probability of prostate cancer in each segment on MR images was recorded with a five-point scale. Areas under the receiver operating characteristic curve (AUCs) were compared by using the Z test; sensitivity and specificity were determined with the Z test after adjusting for data clustering.
RESULTS: AUC of T2-weighted and ADC data (reader 1, 0.90; reader 2, 0.88; reader 3, 0.76) was greater than that of T2-weighted images (reader 1, 0.79; reader 2, 0.75; reader 3, 0.66) for all readers (P < .0001 in all comparisons). AUC of T2-weighted and ADC data was greater for readers 1 and 2 than for reader 3 (P < .001). Sensitivity of T2-weighted and ADC data (reader 1, 88%; reader 2, 81%; and reader 3, 78%) was greater than that of T2-weighted images (reader 1, 74%; reader 2, 67%; reader 3, 67%) for all readers (P = .01 for reader 1; P = .02 for readers 2 and 3). Specificity of T2-weighted and ADC data was greater than that of T2-weighted images for reader 1 (88% vs 79%, P = .03) and reader 2 (89% vs 77%, P < .001).
CONCLUSION: The addition of an ADC map to T2-weighted images can improve the diagnostic performance of MR imaging in prostate cancer detection. (c) RSNA, 2008.

Entities:  

Mesh:

Year:  2008        PMID: 19017927     DOI: 10.1148/radiol.2501080207

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  70 in total

1.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation.

Authors:  Kazuhiro Katahira; Taro Takahara; Thomas C Kwee; Seitaro Oda; Yasuko Suzuki; Shoji Morishita; Kosuke Kitani; Yasuyuki Hamada; Mitsuhiko Kitaoka; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2010-07-18       Impact factor: 5.315

Review 2.  Diffusion weighted imaging in prostate cancer.

Authors:  Cher Heng Tan; Jihong Wang; Vikas Kundra
Journal:  Eur Radiol       Date:  2010-10-09       Impact factor: 5.315

Review 3.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements.

Authors:  Gunnar Brix; Jürgen Griebel; Fabian Kiessling; Frederik Wenz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

4.  Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI).

Authors:  Nicola Schieda; Niamh Coffey; Previn Gulavita; Omran Al-Dandan; Wael Shabana; Trevor A Flood
Journal:  Eur Radiol       Date:  2014-04-01       Impact factor: 5.315

5.  Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.

Authors:  Andrew B Rosenkrantz; Hersh Chandarana; Nicole Hindman; Fang-Ming Deng; James S Babb; Samir S Taneja; Christian Geppert
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

6.  Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.

Authors:  Sung Yoon Park; Chan Kyo Kim; Byung Kwan Park; Hyun Moo Lee; Kyung Soo Lee
Journal:  Eur Radiol       Date:  2010-11-03       Impact factor: 5.315

Review 7.  Current use of PSMA-PET in prostate cancer management.

Authors:  Tobias Maurer; Matthias Eiber; Markus Schwaiger; Jürgen E Gschwend
Journal:  Nat Rev Urol       Date:  2016-02-23       Impact factor: 14.432

8.  Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer.

Authors:  Masako Nagayama; Yuji Watanabe; Akito Terai; Tohru Araki; Kenji Notohara; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Satoru Nakashita; Yoshihiro Dodo
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

Review 9.  Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Authors:  Ryan L Brunsing; Natalie M Schenker-Ahmed; Nathan S White; J Kellogg Parsons; Christopher Kane; Joshua Kuperman; Hauke Bartsch; Andrew Karim Kader; Rebecca Rakow-Penner; Tyler M Seibert; Daniel Margolis; Steven S Raman; Carrie R McDonald; Nikdokht Farid; Santosh Kesari; Donna Hansel; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

Review 10.  Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.

Authors:  Michael A Jacobs; Ronald Ouwerkerk; Kyle Petrowski; Katarzyna J Macura
Journal:  Top Magn Reson Imaging       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.